Published • loading... • Updated
Mary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness Products
Summary by Helena Independent Record
22 Articles
22 Articles
Aspen Daily News+21 Reposted by 21 other sources
Mary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness Products
DENVER, April 1, 2026 /PRNewswire/ -- Mary's Medicinals, a subsidiary of MM Brands Inc. (MM Brands), officially announced today its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid therapy trial program. Launched today…
Coverage Details
Total News Sources22
Leaning Left3Leaning Right0Center18Last UpdatedBias Distribution86% Center
Bias Distribution
- 86% of the sources are Center
86% Center
14%
C 86%
Factuality
To view factuality data please Upgrade to Premium
